Knowledge HQ

Ignacio Nunez, COO of CellReady, discusses the importance of sustainability in cell and gene therapy manufacturing at ISCT 2024.

Ignacio Nunez, COO of CellReady, discusses current projects and what the future holds during ASGCT 2024.

Leading industry experts discuss critical strategies to make life-changing treatments more accessible and affordable for patients during ISCT 2024. Hear from top executives at Germfree, Cellular Origins, and CellReady as they discuss innovative solutions to overcome industry challenges. Moderated by ScaleReady.

Rizwan Chaudrey spoke with Ignacio Núñez, COO, CellReady, at ISCT 2024  about the company, its relationship with ScaleReady, what they are showcasing tat ISCT and what makes them unique.

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Wilson Wolf, an innovative leader in cell and gene-modified cell (CGT) manufacturing technology, today announced a collaboration around the automation of Wilson Wolf’s G-Rex® bioreactors.

This technical video describes how Cue Cell Processing System combines its innovative spinning membrane technology with unique fluid dynamics to provide automated, closed-system small volume cell processing with unmatched precision. Cue enables high accuracy concentration, formulation, and aliquoting for cell therapy manufacturing. Applications include cryopreservation preparation, electroporation preparation, and fill/finish.

This technical video describes how Lovo Cell Processing System uses its innovative spinning membrane technology to delivers automated, functionally closed processing for cell therapy manufacturing. Lovo's spinning membrane, combined with software that enables flexible input volumes and cell concentration outputs, is used for various closed-system cell processing applications, including leukapheresis wash, immunomagnetic separation preparation, cultured cell concentration, and thawed product DMSO removal.

This video animation demonstrates a vision toward the industrialization and automation of T cell therapy manufacturing using G-Rex Bioreactors.

Video was created by Wilson Wolf Manufacturing Corporation.

In this video you will learn how G-Rex bioreactors solve the limitations of flask and bag-based cell therapy manufacturing. By providing cells with uninterrupted access to oxygen and nutrients, the G-Rex cell culture device is the only accessible cell expansion technology that linearly scales to meet the demands of cell therapy manufacturers.

This video features Juan Vera, Chief Development Officer at Marker Therapeutics, discussing how Marker used G-Rex Bioreactors and the Lovo Cell Processing System to evolve and simplify manufacturing of its multiple tumor-associated antigen (MultiTAA) T cell therapy in anticipation of commercialization.

This ScaleReady-sponsored seminar originally aired at the CAR-TCR Virtual 2021 Conference (Hanson Wade) on September 1st, 2021.